MP69: Bladder Cancer: Upper Tract Transitional Cell Carcinoma I

Poster Session Moderator(s)

• MF

  Mario Fernandez, MD

  Associate Professor
• 

  Mantu Gupta, MD,FRCS

  Icahn School of Medicine at Mount Sinai

Presentations:

• 3:30 PM – 5:30 PM CST

  MP69-01: Establishment of a novel animal model in carcinogenesis of upper tract urothelial carcinoma and its gene profile
  

  Poster Presenter: Akinaru Yamamoto, MD – Department of Urology, Osaka University Gradu
• 3:30 PM – 5:30 PM CST

  MP69-02: Clinical impact of cancer predisposing genes on Upper Urinary Tract Urothelial Carcinoma: a large scale genome analysis in Japan
  

  Poster Presenter: Yuya Sekine, MD,Phd – Department of Urology, Akita University Graduate S
• 3:30 PM – 5:30 PM CST

  MP69-03: Examing The Landscape of Concurrent Upper Tract And Lower Tract Urothelial Carcinoma Using Spatial Transcriptomic Analysis
  

  Poster Presenter: Shreyas Naidu
• 3:30 PM – 5:30 PM CST

  MP69-04: Kynurenine pathway is strongly associated with clinicopathological features and response to neoadjuvant chemotherapy in patients with upper tract urothelial carcinoma
  

  Poster Presenter: Kenji Zennami, MD – Fujita Health University
• 3:30 PM – 5:30 PM CST

  MP69-05: Feasibility of DNA Methylation Markers for Diagnosis and Prognosis of Upper Tract Urothelial Carcinoma
  

  Poster Presenter: Farshad Sheybaee Moghaddam, MD – University of Southern California
• 3:30 PM – 5:30 PM CST

  MP69-06: Characteristics of upper urinary tract urothelial carcinoma deficient in Lynch syndrome-related mismatch repair gene expression protein on immunohistochemistry
  

  Poster Presenter: Kenji Tanabe, MD (he/him/his) – Tokyo Medical and Dental University
• 3:30 PM – 5:30 PM CST

  MP69-07: Oncological outcomes of second-look ureteroscopy for upper tract urothelial carcinoma: a single center experience
  

  Poster Presenter: Andrea Gallioli, MD (he/him/his)
• 3:30 PM – 5:30 PM CST

  MP69-08: Follow-up intensity scheme for upper tract urothelial carcinoma after nephron-sparing surgery.
  

  Poster Presenter: Giuseppe Basile, MD
• 3:30 PM – 5:30 PM CST

  MP69-09: A SEER-Medicare Based Quality Score for Patients with Metastatic Upper Tract Urothelial Carcinoma and its Association with Cost and Survival
  

  Poster Presenter: Daniel Joyce, MD
• 3:30 PM – 5:30 PM CST

  MP69-10: Survival Consequences of Omitting Bladder Cuff during Nephroureterectomy for Localized Upper Tract Urothelial Carcinoma
  

  Poster Presenter: Ryan Wong, MD
• 3:30 PM – 5:30 PM CST

  MP69-11: Predictive Nomogram for Post-Nephroureterectomy GFR Estimation
  

  Poster Presenter: Patrick Hensley, MD
• 3:30 PM – 5:30 PM CST

  MP69-12: The Prediction of Renal Function Change after Unilateral Nephroureterectomy in Upper Tract Urothelial Carcinoma Patients by using Tc-99m MAG3 Renal Scan
  

  Poster Presenter: ChenChieh Chen, MD – Taipei Veterans General Hospital
• 3:30 PM – 5:30 PM CST

  MP69-13: Holmium:YAG versus Thulium:YAG laser in endoscopic ablation of Upper Tract Urothelial Carcinoma: a comparison on perioperative outcomes and short-term follow-up
  

  Poster Presenter: Davide Perri, MD
• 3:30 PM – 5:30 PM CST

  MP69-14: The implementation of systematic biopsies in the endoscopic management of upper tract urothelial cancer
  

  Poster Presenter: Andrea Gallioli, MD (he/him/his)
• 3:30 PM – 5:30 PM CST

  MP69-15: Response to Checkpoint Blockade in Patients with Upper Tract Urothelial Carcinoma and Lynch Syndrome
  

  Poster Presenter: Alexander D. Doudt, DO
• 3:30 PM – 5:30 PM CST

  MP69-16: Inpatient outcomes of radical nephroureterectomy for upper tract urothelial cancer, with trends in utilization and impact of robotic surgery: a National Inpatient Sample analysis.
  

  Poster Presenter: Sohrab Arora, MD – Henry Ford Hospital
• 3:30 PM – 5:30 PM CST

  MP69-17: Necessity of prophylactic drainage tube in retroperitoneal laparoscopic nephroureterectomy with open distal ureterectomy: A matched-pair analysis
  

  Poster Presenter: Hiroki Hagimoto, MD – Kobe City Medical Center General Hospital
• 3:30 PM – 5:30 PM CST

  MP69-18: Evaluating the role of lymphvascular invasion as an indicator for adverse outcomes in patients with upper tract urothelial carcinoma and its histological subtypes
  

  Poster Presenter: Ivan Rakic, BS
• 3:30 PM – 5:30 PM CST

  MP69-19: Efficacy of FISH analysis on Urinary Specimens during Endoscopic management of Upper Tract Urothelial Carcinoma
  

  Poster Presenter: Orel Carmona, MD (she/her/hers) – Urology Department, Sheba Medical Center
• 3:30 PM – 5:30 PM CST

  MP69-20: Characterizing the immune phenotype of FGFR3 mutated upper tract urothelial carcinoma (UTUC) using single-cell (sc)RNA-sequencing (seq)
  

  Poster Presenter: Andrew B. Katims, MD, MPH – Memorial Sloan Kettering Cancer Center